tiprankstipranks
Advertisement
Advertisement

OVID Stock Latest News

Ovid Therapeutics Shareholders Back Board and Governance Proposals
Company AnnouncementsOvid Therapeutics Shareholders Back Board and Governance Proposals
10d ago
8K
OVID
Ovid Therapeutics Expands Board, Appoints New Scientific Director
PremiumCompany Announcements
Ovid Therapeutics Expands Board, Appoints New Scientific Director
18d ago
8K
OVID
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
PremiumRatings
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
26d ago
OVID
Ovid Therapeutics price target raised to $7 from $5 at Roth Capital
PremiumThe Fly
Ovid Therapeutics price target raised to $7 from $5 at Roth Capital
1M ago
OVID
Ovid Therapeutics reports Q1 EPS (12c), consensus (11c)
PremiumThe Fly
Ovid Therapeutics reports Q1 EPS (12c), consensus (11c)
1M ago
OVID
OVID Earnings this Week: How Will it Perform?
PremiumPre-EarningsOVID Earnings this Week: How Will it Perform?
1M ago
OVID
Ovid Therapeutics files to sell 29.86M shares of common stock for holders
Premium
The Fly
Ovid Therapeutics files to sell 29.86M shares of common stock for holders
2M ago
OVID
Ovid Therapeutics Boosts Capital Through Warrant Exercises
Premium
Company Announcements
Ovid Therapeutics Boosts Capital Through Warrant Exercises
2M ago
8K
OVID
Ovid Therapeutics: Differentiated KCC2 ‘Master Switch’ Platform and Strong Cash Runway Underpin Buy Rating
PremiumRatings
Ovid Therapeutics: Differentiated KCC2 ‘Master Switch’ Platform and Strong Cash Runway Underpin Buy Rating
2M ago
OVID
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
PremiumRatings
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
2M ago
OVID
Ovid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
2M ago
OVID
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
2M ago
IVA
OVID
Ovid Therapeutics price target raised to $7 from $5 at Wedbush
PremiumThe FlyOvid Therapeutics price target raised to $7 from $5 at Wedbush
3M ago
OVID
Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines
Premium
Company Announcements
Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines
3M ago
OVID
Ovid Therapeutics price target raised to $5 from $3 at Roth Capital
Premium
The Fly
Ovid Therapeutics price target raised to $5 from $3 at Roth Capital
3M ago
OVID
Ovid Therapeutics: Advancing OV329 Pipeline, De‑Risked Differentiation, and Strong Cash Runway Support Buy Rating
PremiumRatings
Ovid Therapeutics: Advancing OV329 Pipeline, De‑Risked Differentiation, and Strong Cash Runway Support Buy Rating
3M ago
OVID
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
PremiumThe Fly
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
3M ago
M
CF
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
PremiumTipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
3M ago
CING
OVID
Ovid Therapeutics Raises Capital to Expand Epilepsy Pipeline
PremiumCompany Announcements
Ovid Therapeutics Raises Capital to Expand Epilepsy Pipeline
3M ago
8K
OVID
Ovid Therapeutics announces Phase 1 clearance for OV4071
PremiumThe FlyOvid Therapeutics announces Phase 1 clearance for OV4071
3M ago
OVID
Ovid Therapeutics reports Q4 EPS 6c, consensus (10c)
Premium
The Fly
Ovid Therapeutics reports Q4 EPS 6c, consensus (10c)
3M ago
OVID
Ovid Therapeutics sees cash runway into late 2028
Premium
The Fly
Ovid Therapeutics sees cash runway into late 2028
3M ago
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >